Exploring the Potential for Subcutaneous Delivery of ADCs

  • Reviewing clinical use and benefits of recombinant human hyaluronidase PH20 (rHuPH20) and potential application to ADCs
  • Demonstrating safe preclinical subcutaneous administration of an ADC
  • Improving preclinical pharmacokinetics of ADCs delivered subcutaneously